Friday, October 7, 2011

ZELTIQ Aesthetics Sets IPO Range

Pleasanton-based ZELTIQ Aesthetics, the developer of an aesthetic medical product used for selectively reducing fat bulges, has set its initial IPO range, according to an updated S-1 from the company today. ZELTIQ said it estimates its IPO price will be between $14.00 and $16.00 per share. The firm is offering a total of 7,000,000 shares of its common stock, and has been approved to list on the NASDAQ Global Market as ZLTQ. The firm's IPO is being underwritten by J.P. Morgan, Goldman Sachs & Co., William Blair & Company, and Canaccord Genuity. Zeltiq is venture backed by Advanced Technology Ventures, Aisling Capital, Frazier Healthcare Ventures, Venrock, among others.